Has Mastan Lokireddy received payments from drug or device companies?

Yes. Drug and device makers reported $1,633 in general payments to Mastan Lokireddy across 39 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Mastan Lokireddy did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Mastan Lokireddy come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Mastan Lokireddy

Child & Adolescent Psychiatry · Brooklyn, NYNPI 1124431440

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 39 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 10 manufacturers reported payments, led by Alkermes, Inc. at 28.2% of the total. Reporting peaked in 2019 at $910 and has fallen 85.4% since, to $133 in 2025.

$1,633in general payments, 2019–2025

Across 39 payments — averaging $41.86 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Alkermes, Inc.$460
Johnson & Johnson$298
Avanir Pharmaceuticals, Inc.$250
Teva Pharmaceuticals USA, Inc.$141
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$140
E.r. Squibb & Sons, L.L.C.$133
plus $210 from 4 others

What the payments were for

Food & beverage$1,633100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Alkermes, Inc.	18	$460
Johnson & Johnson	9	$298
Avanir Pharmaceuticals, Inc.	2	$250
Teva Pharmaceuticals USA, Inc.	2	$141
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)	2	$140
E.r. Squibb & Sons, L.L.C.	1	$133
Indivior Inc.	1	$125
Otsuka America Pharmaceutical, Inc.	2	$47
Lundbeck LLC	1	$21
Neurocrine Biosciences, Inc.	1	$17

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,633 in reported general payments places this provider in the 80th percentile of 317 child & adolescent psychiatry providers in New York.

See all child & adolescent psychiatry providers in New York →

Medicare billing

Part B allowed, 2024

$3,484

Medicare patients

Services billed

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Aripiprazole	92	$2,587
Hydroxyzine Hcl	123	$1,362
Zolpidem Tartrate	197	$1,127
Dextroamphetamine-Amphet ErDextroamphetamine/Amphetamine	15	$1,059
Duloxetine Hcl	21	$609
Clonazepam	152	$541
Mirtazapine	43	$489
Oxcarbazepine	12	$476
Trazodone Hcl	115	$454
Quetiapine Fumarate	63	$436
Bupropion XlBupropion Hcl	33	$423
Bupropion Hcl SrBupropion Hcl	19	$386
Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine	22	$329
Buspirone Hcl	27	$300
Divalproex Sodium	24	$270

Paid to pharmacies, not to this prescriber.

Other child & adolescent psychiatry in Brooklyn

Marie CharlesBrooklyn$11K
Felix SterlingBrooklyn$6K
Fahim QureshiBrooklyn$6K
Faina YablochnikovaBrooklyn$3K
Zu FashanBrooklyn$3K
Mirielle DupervalBrooklyn$2K
Manoj ShahBrooklyn$1K
Matthew LorberNew York$398K
Mitchell CabisudoNew Windsor$346K
Parinda ParikhWhite Plains$185K

See the full list for New York →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →